The Challenges of USP 800 for Compounding Pharmacies
In this clip, Jeffrey Lombardo, PharmD, who is the executive patient safety officer for University at Buffalo's patient safety organization Empire State Patient Safety Assurance Network, explains the challenges compounding pharmacies will face with USP800.
In this clip, Jeffrey Lombardo, PharmD, who is the executive patient safety officer for University at Buffalo's patient safety organization Empire State Patient Safety Assurance Network, explains the challenges compounding pharmacies will face with USP800. Lombardo was featured on a panel that was held simultaneously with The 36th Annual Chemotherapy Foundation Symposium CFS®. held November 7 to 9, 2018, at the New York Marriott Marquis in New York, New York.
Jeffrey Lombardo, PharmD:
One of the challenges for compounding pharmacists for USP800 is understanding using closed system transfer devices is a recommendation for compounding, but really not mandated when you infuse those drugs to the patient in the bedside or in the chair. Under the USP800 standard, utilizing the closed system transfer devices really is going to be needed in order to meet compliance and code. The financial burden, the outlay, and the selection of what closed system transfer device you should be using is also a question for some of the practices.
